A 28-year-old woman with Graves' disease has been on methimazole 20 mg daily for 6 weeks and is now euthyroid (TSH 1.2 mIU/L, free T4 12 pmol/L). She is keen to avoid radioactive iodine and surgery. She asks about long-term management options. What is the most appropriate next step?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.